Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Lianluo Smart Expands Its Wearable Sleep Diagnostic Products into More Than 20 Medical Examination Centers in Beijing 2019-01-22 22:00
United Imaging Healthcare uEXPLORER Total-body Scanner Cleared by FDA, Available in U.S. Early 2019 2019-01-22 21:00
TaiwanJ Pharmaceuticals Announces Positive Results from Phase 2 Orphan Drug Designation Study of JKB-122 on Autoimmune Hepatitis (AIH) 2019-01-22 10:45
New Device that can Rapidly Diagnose Disease Could Save Lives 2019-01-22 06:22
OliX Announces Clinical Candidate Nomination for the Treatment of Geographic Atrophy 2019-01-18 14:50
Erasmus University MC investigating a new surgical matrix to reduce post-operative complications 2019-01-16 23:24
Neurotech Pharmaceuticals, Inc. and Lowy Medical Research Institute Announce Publication of NT-501 Phase 2 Results 2019-01-16 22:34
Bridge Biotherapeutics Announces FDA Orphan Drug Designation for BBT-877 in Idiopathic Pulmonary Fibrosis (IPF) 2019-01-16 22:00
Luye Pharma Reaches Strategic Partnership with AstraZeneca, Strengthens Commitment to Cardiovascular Therapeutic Field 2019-01-16 19:08
Lianluo Smart Expands Its Sleep Diagnostic Offering Into More Than Forty Major Public Hospitals in China 2019-01-15 22:00
MGI Announces Price and Early Access Customer of MGISEQ-T7 2019-01-10 05:51
/CORRECTION/ -- NapaJen Pharma, Inc./ 2019-01-09 21:52
NapaJen Pharma Closes $12.4 Million Series C Financing 2019-01-09 14:00
Adagene Announces Collaboration for Discovery of Novel CAR-T with the National Heart, Lung, and Blood Institute at the National Institutes of Health (NIH) 2019-01-08 09:44
China Biologic Reiterates Full Year 2018 Financial Forecast 2019-01-07 21:00
Uni-Bio Science's Anti-diabetic Acarbose Oral Tablets BE Study Application Accepted by the National Medical Products Administration 2019-01-05 01:04
OrigiMed Completes Series B Round Focusing on Creating a Comprehensive Precision Medicine Platform for Oncology 2019-01-04 09:30
Adlai Nortye Announces Clinical Collaboration with Merck to Evaluate Adlai Nortye's AN0025 (EP4 Antagonist) in Combination with KEYTRUDA® (pembrolizumab) in Patients with Solid Tumors 2019-01-03 16:00
China SXT Pharmaceuticals, Inc. Announces First Closing of Initial Public Offering 2019-01-03 02:30
MabSpace Biosciences Merged with HJB to Form Transcenta Holding, a Fully Integrated Leading Global Biotherapeutics Company 2019-01-02 12:37
1 226 227 228 229 230 429